Cara Therapeutics Inc (NASDAQ:CARA)

28.53
Delayed Data
As of Apr 16
 +0.22 / +0.78%
Today’s Change
12.30
Today|||52-Week Range
29.65
+88.57%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Cara Therapeutics Inc have a median target of 35.00, with a high estimate of 47.00 and a low estimate of 21.00. The median estimate represents a +22.68% increase from the last price of 28.53.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Cara Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.58
Sales
$2.4M
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -136.37%
 
 
 
 
 
 
Growthannually -1,165.08%
 
 
 
 
 
 

Sales

Growthquarterly -97.90%
 
 
 
 
 
 
Growthannually -77.61%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.